March 13, 2020 07:41 AM EDTUpdated 11:16 AM
R&D
Coronavirus

Eli Lil­ly teams with an­ti­body up­start Ab­Cellera in coro­n­avirus hunt

Jason Mast

Editor

As the Covid-19 out­break reach­es of­fi­cial pan­dem­ic lev­els and be­gins to dis­rupt US life in un­prece­dent­ed ways, Eli Lil­ly is join­ing the hunt for a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times